2021 annual financial data
Amylyx Pharmaceuticals 2021 Operating cash flow
Amylyx Pharmaceuticals 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -74,799,000 USD.
Operating income was -82,688,000 USD and net income was -87,879,000 USD.
Operating cash flow was -74,799,000 USD.
Get free Amylyx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 285,000 USD
- Operating income
- -82,688,000 USD
- Net income
- -87,879,000 USD
- Operating cash flow
- -74,799,000 USD